Lithium sulphate prolonged-release 660 mg

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Lithium sulphate prolonged-release 660 mg
Treatment and conditionWhere it standsTrials
Lithium sulphate prolonged-release 660 mg for bipolar disorderTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Lithium sulphate prolonged-release 660 mg for tremorTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1